Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.30 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7618235 | 0.99 | MAPT (0.34) | MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL7624569 | 0.92 | TBXAS1 (0.36) | MAPTTBXA2RTBXAS1 | |
| SCHEMBL7621105 | 0.92 | TBXA2R (0.34) | TBXA2RTBXAS1 | |
| SCHEMBL7628012 | 0.91 | TBXAS1 (0.36) | MAPTHPGDMAPK1L3MBTL1TBXA2R | |
| SCHEMBL7623039 | 0.91 | PSEN1 (0.31) | — | |
| SCHEMBL7617751 | 0.91 | TBXA2R (0.34) | MAPTHPGDMAPK1L3MBTL1TBXA2R | |
| SCHEMBL7617025 | 0.90 | MAPT (0.31) | MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL7622414 | 0.90 | — | — | |
| SCHEMBL7625484 | 0.89 | MAPT (0.30) | MAPTHPGDMAPK1L3MBTL1 | |
| SCHEMBL7621844 | 0.89 | PSEN1 (0.39) | TBXA2RTBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6448444-B2 | INSECTICIDES, MITICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-10 | — | — | US | disclosed |
| US-6437184-B1 | INSECTICIDES, ACARICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-08-20 | — | — | US | disclosed |
| US-20020019569-A1 | Oxime compounds, their use, and intermediates for their production | SUMITOMO CHEMICAL COMPANY, LIMITED | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019569-A1 | Oxime compounds, their use, and intermediates for their production | CBR3, CBR1, NOX3 | MAPT 4623/4885HPGD 881/4885MAPK1 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.